28 träffar

ArticleEchocardiography
Tricuspid regurgitation (TR/TI)

…venous system, resulting in dilation of vena cava inferior ( 2.1 cm). Severe tricuspid regurgitation may lead to systolic reversal in the hepatic veins. This…

ArticleCardiology
PCSK9 Inhibitors: Indications, Efficacy and Access

…coronary heart disease, whereas loss of function variants are associated with protection from cardiovascular disease. Pharmacological PCSK9 inhibition increases the effective availability of hepatic LDL…

ArticleReferensvärden
Renal parameters

…patients with hepatic cirrhosis — creatinine based eGFR substantially overestimates renal function. Staging of chronic kidney disease Stage eGFR Description : : : G1 ≥ 90 Normal or high G2…

ArticleCardiology
Inclisiran and Emerging Lipid-Lowering Agents

…when additional LDL C reduction is required, including in patients with atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolaemia. The broader therapeutic principle is that…

ArticleCardiology
Lipid-Lowering Therapy: Statins as First-Line Treatment

…Clinical indications and treatment goals Established atherosclerotic cardiovascular disease Patients with established ASCVD are at very high cardiovascular risk and require intensive LDL C lowering…

ArticleCardiology
Alcohol and Cardiovascular Disease

…exposure produces transient haemodynamic and myocardial effects, whereas sustained heavy consumption is associated with hypertension, coronary artery disease, arrhythmias, heart failure and alcohol related cardiomyopathy…

ArticleCardiology
Bempedoic Acid: Evidence and Clinical Use

…A reductase in the cholesterol synthesis pathway. Inhibition of ACL reduces hepatic cholesterol synthesis and produces reductions in LDL C, non high density lipoprotein cholesterol…

ArticleCardiology
Cardiac amyloidosis

…history of increasing frequency of hospitalizations and visits for heart failure without disease recognition in the 3 years preceding diagnosis is also a notable red…

ArticleCardiology
Ivabradine: Indications, Dosing and Heart-Rate Targets

…in selected circumstances. Ivabradine undergoes extensive first pass hepatic metabolism through CYP3A4. Dose adjustment is required in severe hepatic or renal impairment, and clinically relevant…

ArticleCPR
Cardiac arrest in intoxication (poisoning)

…vital functions artificially until the substance undergoes renal elimination, hepatic elimination or is removed by means of dialysis. Substance Antidot e Paracetamol (Acetaminophen) N Acetylcysteine…

ArticleProcedurer
Warfarin therapy

…anticoagulants (DOACs) are contraindicated. Antiphospholipid syndrome, particularly triple positive disease or after an arterial event, where DOACs have proved inferior. Atrial fibrillation with marked renal…

ArticleKunskapsbas
🟠 Prasugrel (Effient, Efient, Prasita)

…renal disease. Limited experience exists for patients with impaired renal function. Hepatic impairment No dose adjustment is required for patients with mild to moderate hepatic…

ArticleCardiology
Aspirin in Primary Prevention: Current Recommendations

…increasing particularly after 70 years Male sex Previous upper gastrointestinal disease Hepatic or renal disease Multiple cardiovascular risk factors Concomitant nonsteroidal anti inflammatory drugs Corticosteroid…

ArticleCardiology
Dietary Patterns and Cardiovascular Outcomes

…craving, glucose–insulin responses, gut peptides, hepatic fat synthesis, adipocyte function and metabolic expenditure. Consequently, obesity is only one pathway through which diet affects cardiovascular…

ArticleKunskapsbas
🟠 HEMORR₂HAGES Bleeding Risk Score

…Components of the HEMORR₂HAGES Score The acronym HEMORR₂HAGES represents the following parameters: H epatic or renal disease (1 point) E thanol abuse (1 point) M…